Now, cancer patients can have easier access to morphine

The availability of the drug was under strict regulation under the existing Act of 1985 which mandated patients to go through a few rounds of paperwork before availing it

Press Trust of India New Delhi
Last Updated : Feb 21 2014 | 8:16 PM IST
Cancer patients will have easier access to pain-killer morphine drugs with Parliament today passing a bill that also provides for control and regulation of narcotic drugs.

Moving the Narcotic Drugs and Psychotropic Substances (Amendment) Bill, 2011 for consideration and passage in Rajya Sabha, Minister of State for Finance J D Salem said though India produced 90 per cent of morphines in the world, these were not easily available in leading city hospitals.

"We need to get the crop, but at the same time, we will have to be cautious against trafficking. We need to make the drug available," he said, adding with the passage of legislation, availability of morphines would go up by 40 per cent. Morphin is a derivative of opium.

The availability of the drug was under strict regulation under the existing Act of 1985 which mandated patients to go through a few rounds of paperwork before availing it.

The Lok Sabha yesterday passed the Bill simplifying the regulations for procuring and possessing narcotic drugs when used for medicinal purposes. The then Finance Minister Pranab Mukherjee introduced the Bill in the lower house in 2011.

Responding to a question on the misuse of narcotics, he urged the states through members to keep a tab saying, "Law is just a law. The question is how effectively and efficiently it is used."

The amendments prescribe the forms and conditions of the licence or permits for the manufacture, possession, transport, import inter-state, export inter-state, sale, purchase, consumption or use of essential narcotic drugs and charge a fee for that.

The Indian Association of Palliative Care (IAPC) had been pushing for the passage of the amendment Bill in Parliament.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 21 2014 | 8:10 PM IST

Next Story